# Esophageal submucosal gland duct adenoma: a case report and literature review

**Authors:** Bing Zhou, Jian Zheng, Ling Huang, Hua Hao

PMC · DOI: 10.3389/fonc.2025.1525781 · Frontiers in Oncology · 2025-02-06

## TL;DR

This paper reports a rare benign tumor in the esophagus and reviews existing cases to improve diagnosis and treatment strategies.

## Contribution

The study adds a new case of ESGDA and provides insights into its clinical and pathological features to aid in accurate diagnosis.

## Key findings

- ESGDA commonly occurs in the lower esophagus of elderly patients and presents with atypical symptoms.
- Microscopic and immunohistochemical features help distinguish ESGDA from other tumors.
- Complete endoscopic resection is recommended for diagnosis and treatment to prevent misdiagnosis.

## Abstract

Esophageal submucosal gland duct adenoma (ESGDA) is a rare, benign tumor with non-specific clinical features and imaging findings, often leading to misdiagnosis.

In this report we describe the clinicopathological features of a new-onset case of ESGDA and review 19 previously-reported ESGDA cases in the literature.

The median age of the 20 patients was 70 years, and the male-to-female ratio was 5:2. Lesions located in the lower esophagus accounted for 81% of the cases. Chest and abdominal discomfort were the main clinical symptoms, and endoscopic findings mostly included polypoid masses that were impossible to correctly diagnose prior to excision and biopsy. On microscopic examination, the submucosal tumor was found to be composed of glandular cavities of various sizes, bland cytology with infrequent mitotic figures, and the interstitium was infiltrated by a large number of lymphocytes. Immunohistochemical analysis revealed the expression of adenomyoepithelial cytokeratins (CK) CK7, CK5/6, and p63. Local tumor resection was performed, the longest follow-up period was 132 months of the 20 patients, the prognosis was favorable, and no recurrence or metastasis.

ESGDA is more common in the lower esophagus in elderly patients, and its clinical symptoms are atypical. Taking into account its characteristic microscopic morphology and immunohistochemical markers, the possibility of this rare disease should be considered to avoid misdiagnosis or missed diagnosis. Complete en bloc resection with Endoscopicp may be the best strategy for both the diagnosis and treatment of this entity.

## Linked entities

- **Proteins:** KRT7 (keratin 7), ck56 (hypothetical protein), RPE65 (retinoid isomerohydrolase RPE65)

## Full-text entities

- **Genes:** CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}, TP63 (tumor protein p63) [NCBI Gene 8626] {aka AIS, B(p51A), B(p51B), EEC3, KET, LMS}, KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}
- **Diseases:** abdominal discomfort (MESH:D000007), ESGDA (MESH:D002759), metastasis (MESH:D009362), masses (MESH:C536030), benign tumor (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11848948/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11848948/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC11848948/full.md

---
Source: https://tomesphere.com/paper/PMC11848948